A retrospective analysis of patients treated for gestational trophoblastic diseases: a 4-year experience of a tertiary hospital

Aim: To study incidence, clinical outcome, and follow-up data of the gestational trophoblastic disease (GTD) in patients diagnosed in the present Department. Materials and Methods: This study included the authors' retrospective clinical records regarding the cases of GTD which were diagnosed and followed up between January 2011 and January 2015. Patients' age, gravidity and parity, obstetric history, subgroup of GTD, gestational weeks, management results, and pre-post treatment β-hCG levels was investigated and an incidence study was constituted. Results: Total of 56 GTD cases were hospitalized and clinical records of 16,840 normal spontaneous deliveries were evaluated during the study period. The incidence of GTD was 3.3/1,000 cases. After histopathological examination, nine of 47 cases were partial molar pregnancy, whereas 38 cases were complete moles. There were no choriocarcinoma and invasive moles. All cases were treated with vacuum curettage without complication. Conclusion: The GTD incidence in this clinic is high with a rate of 3.3/1,000 per pregnancy compared to Turkish literature. High birth rates of our population may play a role in high incidence results. Further investigation in this field is essential.

Molar pregnancy; β-HCG; Methotrexate; Abortus; Bleeding.

[1] Rustin G.J.S.: “Trophoblastic diseases”. In: Shaw R.W., Soutter W.P., (eds). Gynaecology. 2nd Ed., London: Churchill Livingstone, 1997, 605.

[2] Tham B.W., Everard J.E., Tidy J.A., Drew D., Hancock B.W.: “Gestational trophoblastic disease in the Asian population of Northern England and North Wales”. BJOG, 2003, 110, 555.

[3] Ozalp S.S., Oge T.: “Gestational trophoblastic diseases in Turkey”. J. Reprod. Med., 2013, 58, 67.

[4] Fowler D.J., Lindsay I., Seckl M.J., Sebire N.J.: “Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center”. Ultrasound Obstet. Gynecol., 2006, 27, 56.

[5] Kohorn E.I.: “The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment”. Int. J. Gynecol. Cancer, 2001, 11, 73.

[6] Palmer J.R.: “Advances in the epidemiology of gestational trophoblastic disease”. J. Reprod. Med., 1994, 39, 155.

[7] Buckley J.D.: “The epidemiology of molar pregnancy and choriocarcinoma”. Clin. Obstet. Gynecol., 1984, 27, 153.

[8] Surti U., Szulman A.E., O’Brien S.: “Dispermic origin and clinical outcome of three complete hydatidiform moles with 46, XY karyotype”. Am. J. Obstet. Gynecol., 1982, 144, 84.

[9] Berkowitz R.S., Bernstein M.R., Harlow B.L., Rice L.W., Lage J.M., Goldstein D.P., Cramer D.W.: “Case-control study of risk factors for partial molar pregnancy”. Am. J. Obstet. Gynecol., 1995, 173, 788.

[10] Berkowitz R.S., Goldstein D.P.: “Epidemiology, genetics and molecular biology of gestational trophoblastic disease”. In: Gershenson D.M., McGuire W.P., Gore M., Quinn M.A., Thomas G., (eds). Gynecologic cancer controversies in management. 1sted. Philadelphia PA: Elsevier, 2004, 545.

[11] Ngan H.Y.S., Wong L.C., Ma H.K.: “Reproductive performance of patients with gestational trophoblastic disease in Hong Kong”. Acta Obstet. Gynaecol. Scand., 1988, 67, 11.

[12] Uberti E.M., Fajardo Mdo C., Ferreira S.V., Pereira M.V., Seger R.C., Moreira M.A., et al.: “Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy”. Gynecol. Oncol., 2009, 115, 476.

[13] Yen S., MacMahon B.: “Epidemiologic features of trophoblastic disease”. Am. J. Obstet. Gynecol., 1968, 101, 126.

[14] Matalon M., Modan B.: “The Epidemiologic aspects of hydatidiform mole in Israel”. Am. J. Obstet. Gynecol., 1972, 112, 107.

[15] Sand P.K., Lurain J.R., Brewer J.I.: “Repeat gestational trophoblastic disease”. Obstet. Gynecol., 1984, 63, 140.

[16] Marguez-Monter H., de la Vega G.A., Ridaura C., Robles M.: “Gestational choriocarcinoma in the general hospital of Mexico”. Cancer, 1968, 22, 91.

[17] Hsu CT, Chen TY, Chiu WH., Yang C.C., Lai C.H., Chancheng C.H., et al.: “Some aspects of trophoblastic diseases peculiar to Taiwan”. Am. J. Obstet. Gynecol., 1964, 90, 308.

[18] MacGregor C., Ontiveros E., Vargas E., Valenzuela S.: “Hydatidiform mole”. Obstet. Gynecol., 1969, 33, 343.

[19] Martin P.M.: “High frequency of hydatidiform mole in native Alaskans”. Int. J. Gynaecol. Obstet., 1978, 15, 395.